This is a preview of subscription content, log in via an institution to check access.
Reference
Decision Resources. The Market for Non-Small-Cell Lung Cancer (NSCLC) Will Grow to $7 Billion in 2022, Fuelled by the Entry of Twelve Novel Agents. Media Release : 12 Dec 2013. Available from: URL: http://www.decisionresources.com
Rights and permissions
About this article
Cite this article
Targeted therapies will drive NSCLC market. PharmacoEcon Outcomes News 694, 8 (2014). https://doi.org/10.1007/s40274-014-0976-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-0976-y